Investor Calendar Invites You to the Amarin First Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, May 3, 2017

BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / May 2, 2017 / Amarin Corporation plc AMRN will host a conference call and live webcast to discuss the results of the first quarter 2017, to be held Wednesday, May 3, 2017 at 8:00 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on May 17, 2017.

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes a commitment to an ongoing outcomes study. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

SOURCE: Investor Calendar

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!